Impact of Modified Feeding Protocol on Neonatal Outcomes
- Conditions
- PretermBirth WeightFeeding Disorder Neonatal
- Registration Number
- NCT06246032
- Lead Sponsor
- Imam Abdulrahman Bin Faisal University
- Brief Summary
The goal of this clinical trial is to compare modified feeding protocol and current feeding protocol on neonatal outcomes in preterm infants who born with weight less than 2kg.
The main questions it aims to answer are:
* Is Modified feeding protocol will decrease the duration of parenteral nutrition and length of hospital stay?
* Is Modified feeding protocol feasible, efficient, and safe in preterm infants?
Participants will undergo the modified feeding protocol since birth until discharge.
- Detailed Description
two group in this study Prospective group: intervention group will undergo the modified feeding protocol Retrospective group: intervention group will undergo the current feeding protocol
Both group will have care as routine care to this kind of patients But the differ will be in feeding protocol as initiation rate, advancement rate, human milk fortification rate
The outcomes of both group will be compeered to meet the study objectives
Recruitment & Eligibility
- Status
- ACTIVE_NOT_RECRUITING
- Sex
- All
- Target Recruitment
- 30
- Birth weight (<2000g)
- Gestational Age (<37 week)
- Metabolic Disorders
- Congenital Heart Diseases
- Chronic Lung Disease
- Congenital Anomalies (can related to feeding)
- Moderate to severe GERD
- Necrotizing enterocolitis stage 3 (surgical)
- Gastrointestinal surgery
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Primary Outcome Measures
Name Time Method Duration of Total Parenteral Nutrition (TPN) up to 2 weeks Number of days that participant received Total Parenteral Nutrition (TPN)
Length of Stay (LOS) Up to 8 weeks Number of days that participant stayed at hospital
- Secondary Outcome Measures
Name Time Method Incidence of Feeding intolerance Up to 8 weeks abdominal grith more than 2 cm, gastric residual 50% of the last feed.
Incidence of Necrotizing Enterocolitis Up to 8 weeks Stage 2, Stage 3
Trial Locations
- Locations (1)
Maternity and Children Hospital
🇸🇦Dammam, Eastern, Saudi Arabia
Maternity and Children Hospital🇸🇦Dammam, Eastern, Saudi Arabia